0

Global Progressive Supranuclear Palsy Therapeutics Market 2019-2023

  • Published: May 2019
  • Pages: 124
  • SKU: IRTNTR31276
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The global progressive supranuclear palsy therapeutics market size will grow by USD 14.95 million during 2019-2023. This report provides a detailed analysis of the market by product (dopamine, anticholinergic agents, tricyclic antidepressants, and others) and geography (Asia, Europe, North America, and ROW). The report analyzes the market’s competitive landscape and offers information on several progressive supranuclear palsy therapeutics companies including AbbVie Inc., Acorda Therapeutics Inc., Biogen Inc., Bristol-Myers Squibb Co., and Merck & Co. Inc.

Some of the key findings from our progressive supranuclear palsy therapeutics market forecast report are summarized below

Progressive Supranuclear Palsy Therapeutics Market

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!

Global progressive supranuclear palsy therapeutics industry overview

As progressive supranuclear palsy is rare and affects a limited patient group, a majority of the global population is unaware of the disease. This has induced organizations across the world to conduct awareness programs to educate people about the disease. Several organizations are providing funds for researchers researching the treatment of rare neurodegenerative disorders such as progressive supranuclear palsy. Many vendors across the globe are also conducting awareness campaigns to educate people regarding the diagnosis of the disease. This will result in increased awareness and the early diagnosis of the disease, which will be a significant factor driving the growth of the market during the forecast period.

The unmet need for the treatment of progressive supranuclear palsy has encouraged various pharmaceutical vendors, research institutes, and biotechnology firms to develop novel therapies for treatment. This has resulted in the presence of a strong pipeline of early and mid-stage therapies for the treatment of progressive supranuclear palsy. Though market might not witness the approvals for the early-stage therapies over the forecast period, advancements in research will result in the entry of more vendors. This will subsequently attract investors who will fund several pharmaceutical companies. As a result of such factors, the market will register a CAGR of almost 5% during the forecast period.

Top progressive supranuclear palsy therapeutic companies covered in this market research report

The global progressive supranuclear palsy therapeutics market is highly concentrated. To help clients improve their revenue, this report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies. Key insights provided by this progressive supranuclear palsy therapeutics market analysis report will helps clients create strategies to make the most of future growth opportunities.

The report offers a detailed analysis of several companies, including:

  • AbbVie Inc.
  • Acorda Therapeutics Inc.
  • Biogen Inc.
  • Bristol-Myers Squibb Co.
  • Merck & Co. Inc.

Progressive supranuclear palsy therapeutics market segmentation based on product

  • Dopamine
  • Anticholinergic agents
  • Tricyclic antidepressants
  • Others

The dopamine segment will account for the largest global supranuclear palsy therapeutics market share. Dopamine drugs such as carbidopa-levodopa are the most-effective treatment option for the motor symptoms of progressive supranuclear palsy in the early stages. Dopamine agonists are also used as the first line of treatment to avoid the side effects associated with the treatment using carbidopa-levodopa. The lack of approved novel therapies for the treatment of progressive supranuclear palsy is expected to drive the growth of the market in this product segment.

Progressive supranuclear palsy therapeutics market segmentation based on geography

  • Asia
  • Europe
  • North America
  • ROW

North America is the largest market for progressive supranuclear palsy therapeutics market. The increasing number of awareness programs by various organizations in the region towards educating the general population about the disease and the advancements in drug research will influence region’s contribution to the progressive supranuclear palsy therapeutics market size in North America.

Key highlights of the global progressive supranuclear palsy therapeutics market for the forecast years 2019-2023:

  • CAGR of the market during the forecast period 2019-2023
  • Detailed information on factors that will accelerate the growth of the progressive supranuclear palsy therapeutics market during the next five years
  • Precise estimation of the global progressive supranuclear palsy therapeutics market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the progressive supranuclear palsy therapeutics industry across Asia, Europe, North America, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on several vendors
  • Comprehensive details of factors that will challenge the growth of progressive supranuclear palsy therapeutics companies  

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

 

PART 01: EXECUTIVE SUMMARY              

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: PIPELINE

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Dopamine - Market size and forecast 2018-2023
  • Anticholinergic agents - Market size and forecast 2018-2023
  • Tricyclic antidepressants - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • AbbVie Inc.
  • Acorda Therapeutics Inc.
  • Biogen Inc.
  • Bristol-Myers Squibb Co.
  • Merck & Co. Inc.

PART 15: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 16: EXPLORE TECHNAVIO

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted
Technavio

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Technavio
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>